Shares of pharmaceutical giant Amgen (AMGN) are attempting to bounce back after suffering a steep drop of 7.1% yesterday.

The excitement around the new weight-loss industry is overtaking other disease areas and portfolios for publicly traded ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $35.2, along ...

Trump previously said RFK Jr. would have carte blanche to "go wild" on health-related matters if he became part of Trump's ...

On Wednesday, Sigachi Industries Ltd. made its Q2FY25 and H1FY25 announcements. When compared to Q2FY24, when net revenues ...

Pfizer's drug approvals and advertising revenue could be affected by RFK Jr.'s potential appointment. See why PFE stock is a ...

Stay informed with the Sun Pharma Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of ...

We recently published a list of 10 Top Performing European Stocks Heading into 2025. In this article, we are going to take a ...

Nuvectis Pharma shares fell steeply after updated data from its early-stage study evaluating NXP800 to treat an aggressive type of ovarian cancer showed that a change in the dosing schedule only ...

Stay up-to-date with the Sun Pharma Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on ...

Verona Pharma (Nasdaq: VRNA) is already recording millions of dollars in revenue after launching its lead drug in August ...

The third-quarter earnings season came to an end this week for large drugmakers, with AstraZeneca AZN and Bayer BAYRY ...